MedTrace Logo

The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638)

NCT00894530 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 314

Last updated 2013-11-21

No results posted yet for this study

Summary

The objective of this study is to compare the safety and efficacy of azithromycin ophthalmic solution, 1% versus placebo over a four-week treatment period.

Conditions

  • Blepharitis

Interventions

DRUG

Azithromycin ophthalmic solution, 1%

One drop in each eye twice a day for the first two days; then one drop in each eye once a day for 26 days

DRUG

Placebo

One drop in each eye twice a day for the first two days; then one drop in each eye once a day for 26 days

Sponsors & Collaborators

Principal Investigators

  • Reza Haque, MD,PhD · Medical Monitor, Inspire

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00894530 on ClinicalTrials.gov